Skip to content

Effect of the Ayurvedic medicine Prapunnatbijadi lepa in treatment of Fungal skin infection

Assessment of the prapunnatbijadi lepa in management of dadru (Tinea corporis) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088280
Enrollment
60
Registered
2025-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

None listed

Sponsors

Dr Neelam Subhash Valhekar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having classing signs and symptoms of Tinea corporis i.e. Itching, Erythema vesicles, papules, circular ring like red rash, chronicity, spreading tendency.Patients having chronicity less than 3 years.

Exclusion criteria

Exclusion criteria: Patients with allergic dermatitis, burn, chemical exposure. Patients having renal, hepatic, cardiac diseases, malignancy, AIDS etc. Patients having pregnancy.

Design outcomes

Primary

MeasureTime frame
Efficacy of the Prapunnatbijadi lepa in management of Dadru (Tinea corporis)Timepoint: every 7 days followup for next 30 days

Secondary

MeasureTime frame
assessment of disease status while treatingTimepoint: every 7 days followup for next 30 days

Countries

India

Contacts

Public ContactDr Neelam Subhash Valhekar

Government Ayurved Mahavidyalaya, Dharashiv

gangasagrens@gmail.com9422165970

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026